Insider Shareholders with Direct Ownership of Johnson & Johnson (JNJ)
This section provides a comprehensive overview of the insiders with direct ownership of Johnson & Johnson (JNJ). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
JOHNSON & JOHNSON Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Alex Gorsky
Director |
1,914,937 | 1,213,502 | 766,583 $124 Million | 44 |
Jan 17, 2023
Reduced 32.35%
|
|
Joaquin Duato
CEO and Chairman of the Board |
986,135 | 627,276 | 406,819 $66 Million | 48 |
Feb 14, 2025
Reduced 2.02%
|
| 373,566 | 473,657 | 307,273 $49.9 Million | 6 |
Feb 08, 2013
Reduced 6.82%
|
|
|
Paulus Stoffels
Vice Chair, Exec Committee |
1,098,685 | 824,908 | 275,547 $44.7 Million | 41 |
Feb 12, 2021
Reduced 4.41%
|
|
Jennifer L Taubert
EVP, WWC. Innovative Medicine |
392,712 | 279,762 | 178,013 $28.9 Million | 35 |
Feb 14, 2025
Reduced 4.25%
|
|
Dominic J Caruso
Exec VP, Finance; CFO |
438,696 | 314,993 | 171,659 $27.9 Million | 32 |
Feb 12, 2018
Reduced 8.36%
|
|
Michael H Ullmann
Exec VP, General Counsel |
276,748 | 163,113 | 158,834 $25.8 Million | 50 |
Feb 15, 2022
Reduced 3.76%
|
|
Peter Fasolo
Exec VP, Chief HR Officer |
855,760 | 746,319 | 112,076 $18.2 Million | 59 |
Feb 13, 2024
Reduced 0.42%
|
|
Stephen J Cosgrove
Corporate Controller |
90,183 | 73,002 | 97,011 $15.7 Million | 16 |
Jan 16, 2015
Reduced 4.33%
|
|
Kathryn E Wengel
EVP, Chief TO and Risk Officer |
232,807 | 181,018 | 94,280 $15.3 Million | 40 |
Feb 14, 2025
Reduced 2.48%
|
|
Sandra E Peterson
Exec VP, Group WW Chairman |
178,104 | 94,755 | 83,349 $13.5 Million | 18 |
Feb 12, 2018
Reduced 19.99%
|
|
Thibaut Mongon
Exec VP, WW Chair, Cons Health |
136,811 | 124,463 | 65,915 $10.7 Million | 19 |
Feb 13, 2023
Reduced 8.89%
|
|
Michael E Sneed
EVP, Global Corp Aff & CCO |
208,613 | 186,310 | 62,177 $10.1 Million | 16 |
Feb 12, 2021
Reduced 4.13%
|
|
Ashley Mc Evoy
EVP, WW Chair, MedTech |
193,917 | 151,442 | 52,037 $8.45 Million | 22 |
Aug 23, 2023
Reduced 5.08%
|
|
Gary J Pruden
Exec VP, WW Chair, Med Devices |
27,942 | 37,677 | 43,630 $7.08 Million | 6 |
Feb 28, 2017
Reduced 27.2%
|
|
Mathai Mammen
EVP, Pharm, R&D |
15,158 | 5,701 | 41,934 $6.81 Million | 4 |
Feb 15, 2022
Reduced 7.43%
|
|
William Hait
EVP, Chief EI and Med Officer |
101,636 | 78,985 | 38,647 $6.27 Million | 21 |
Feb 13, 2024
Reduced 1.09%
|
|
Charles Prince
Director |
7,875 | 0 | 28,520 $4.63 Million | 4 |
Dec 14, 2018
Added 6.55%
|
|
Jorge S. Mesquita
Exec VP, WW Chair, Consumer |
59,226 | 31,882 | 27,344 $4.44 Million | 6 |
Feb 11, 2019
Reduced 29.74%
|
|
Leo F Mullin
Director |
13,900 | 9,138 | 26,195 $4.25 Million | 4 |
Oct 16, 2013
Reduced 14.82%
|
|
Vanessa Broadhurst
EVP, Global Corp Affairs |
33,809 | 22,701 | 23,594 $3.83 Million | 22 |
Feb 14, 2025
Reduced 4.05%
|
|
Robert J Decker
VP Corporate Controller |
53,367 | 44,813 | 21,001 $3.41 Million | 33 |
Feb 14, 2025
Reduced 1.74%
|
|
James D. Swanson
EVP, CIO |
28,220 | 10,483 | 18,849 $3.06 Million | 18 |
Feb 14, 2025
Reduced 4.5%
|
|
Ronald A Kapusta
Controller, CAO |
55,091 | 58,137 | 17,757 $2.88 Million | 29 |
Feb 11, 2019
Reduced 5.03%
|
|
William D Perez
Director |
1,500 | 2,692 | 16,030 $2.6 Million | 3 |
Mar 13, 2020
Added 3.02%
|
|
John C Reed
EVP, Innovative Medicine, R&D |
23,605 | 11,369 | 15,542 $2.52 Million | 4 |
Feb 18, 2025
Reduced 2.42%
|
|
David Satcher
Director |
6,300 | 4,437 | 15,393 $2.5 Million | 2 |
Feb 05, 2013
Reduced 22.38%
|
|
Timothy Schmid
EVP, WW Chair, MedTech |
14,298 | 6,388 | 15,098 $2.45 Million | 11 |
Feb 18, 2025
Reduced 2.6%
|
|
Susan L Lindquist
Director |
7,600 | 7,600 | 14,605 $2.37 Million | 2 |
Dec 07, 2012
Reduced 34.23%
|
|
Kristen Mulholland
EVP, Chief HR Officer |
3,438 | 1,008 | 14,119 $2.29 Million | 5 |
Feb 14, 2025
Reduced 3.14%
|
|
Joseph J Wolk
Exec VP, CFO |
145,445 | 141,612 | 14,000 $2.27 Million | 36 |
Feb 14, 2025
Reduced 32.24%
|
|
Mary Sue Coleman
Director |
0 | 2,400 | 11,951 $1.94 Million | 3 |
Nov 12, 2015
Reduced 5.16%
|
|
Elizabeth Forminard
Executive VP, General Counsel |
11,881 | 4,190 | 10,902 $1.77 Million | 15 |
Feb 14, 2025
Reduced 4.08%
|
|
Anne M Mulcahy
Director |
748 | 0 | 6,537 $1.06 Million | 1 |
Dec 14, 2018
Added 10.27%
|
|
Hubert Joly
Director |
5,000 | 0 | 5,000 $811,500 | 1 |
Dec 13, 2019
Added 50.0%
|
|
Marillyn A Hewson
Director |
3,000 | 0 | 3,000 $486,900 | 1 |
Jun 11, 2019
Added 50.0%
|
|
James Cullen
Director |
6,300 | 28,875 | 1,489 $241,664 | 4 |
Sep 10, 2014
Reduced 62.16%
|
|
Mark A Weinberger
Director |
1,000 | 0 | 1,000 $162,300 | 1 |
Dec 12, 2024
Added 50.0%
|